{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:52:32Z","timestamp":1787251952455,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.numecd.2014.01.013","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T17:30:14Z","timestamp":1391103014000},"page":"670-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-1759","authenticated-orcid":false,"given":"S.","family":"Calanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Scicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.K.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Piro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Rabuazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Purrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.numecd.2014.01.013_bib1","first-page":"S67","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.01.013_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1525-1497.2004.40178.x","article-title":"Utility of hemoglobin A1c in predicting diabetes risk","volume":"19","author":"Edelman","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.numecd.2014.01.013_bib3","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2012-3185","article-title":"Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study","volume":"98","author":"Lorenzo","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2014.01.013_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2337\/diacare.13.2.153","article-title":"Management of dyslipidemia in NIDDM","volume":"13","author":"Garg","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.01.013_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.numecd.2009.11.002","article-title":"ApoB\/apoA-I ratio is better than LDL-C in detecting cardiovascular risk","volume":"21","author":"Carnevale Schianca","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.01.013_bib6","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2014.01.013_bib7","doi-asserted-by":"crossref","first-page":"e65210","DOI":"10.1371\/journal.pone.0065210","article-title":"Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese","volume":"8","author":"Li","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2014.01.013_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc Mayo Clin"},{"key":"10.1016\/j.numecd.2014.01.013_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MAJ.0b013e3182018598","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic","volume":"341","author":"Ismail","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.numecd.2014.01.013_bib10","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2014.01.013_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2014.01.013_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2014.01.013_bib13","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2337\/dc13-0792","article-title":"Implications of rising prediabetes prevalence","volume":"36","author":"Abraham","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.01.013_bib14","series-title":"Royal College of Physicians Report: The Medical Consequences of Alcohol Abuse, a Great and Growing Evil","year":"1987"},{"key":"10.1016\/j.numecd.2014.01.013_bib15","first-page":"1077","article-title":"Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group","volume":"45","author":"Mosca","year":"2007","journal-title":"Clin Chem Lab Med CCLM FESCC"},{"key":"10.1016\/j.numecd.2014.01.013_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/oby.20017","article-title":"Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis","volume":"21","author":"Calanna","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.numecd.2014.01.013_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.numecd.2014.01.013_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.numecd.2009.09.003","article-title":"Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction","volume":"21","author":"Spadaro","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.01.013_bib19","first-page":"1104","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.numecd.2014.01.013_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jacl.2012.06.007","article-title":"Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes","volume":"7","author":"Wang","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2014.01.013_bib21","series-title":"National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States","author":"Centers for Disease Control and Prevention","year":"2011"},{"key":"10.1016\/j.numecd.2014.01.013_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-148-5-200803040-00005","article-title":"Brief communication: clinical implications of short-term variability in liver function test results","volume":"148","author":"Lazo","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2014.01.013_bib23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2014.01.013_bib24","first-page":"610","article-title":"An elevated apolipoprotein B\/AI ratio is independently associated with microalbuminuria in male subjects with impaired fasting glucose","volume":"21","author":"Sung","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.01.013_bib25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diacare.22.5.812","article-title":"Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients","volume":"22","author":"W\u00e4gner","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.01.013_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2840-12-26","article-title":"Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988\u20131991 to 2005\u20132008","volume":"12","author":"Ford","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2014.01.013_bib27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0026-0495(96)90246-2","article-title":"Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study","volume":"45","author":"Siegel","year":"1996","journal-title":"Metabolism"},{"issue":"89","key":"10.1016\/j.numecd.2014.01.013_bib28","first-page":"81","article-title":"Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr","volume":"2000","author":"Janssen","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.numecd.2014.01.013_bib29","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.2337\/dc11-0944","article-title":"Low glycated hemoglobin and liver disease in the U.S. population","volume":"34","author":"Christman","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.01.013_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","article-title":"Fatty liver index and mortality: the Cremona study in the 15th year of follow-up","volume":"54","author":"Calori","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2014.01.013_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.numecd.2013.02.004","article-title":"The fatty liver index is associated with increased mortality in subjects referred to coronary angiography","volume":"23","author":"Lerchbaum","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.01.013_bib32","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2014.01.013_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem-64-1-17","article-title":"Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus","volume":"64","author":"Chen","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2014.01.013_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2014.01.013_bib35","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2014.01.013_bib36","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2013-1519","article-title":"Resolution of fatty liver and risk of incident diabetes","author":"Sung","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:22:44Z","timestamp":1746123764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475314000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0939475314000441"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2014.01.013","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2014.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}